Catherine C. Turkel - 26 Apr 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
10 May 2024, 17:16:29 UTC
Previous filing
25 Jul 2023
Next filing
30 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 1,500 26 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +5,000 +50% $0.000000 15,000 26 Apr 2024 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 3,400 26 Apr 2024 Common Shares 3,400 $3.04 Direct
holding LEXX Stock Options 5,000 26 Apr 2024 Common Shares 1,600 $1.96 Direct
holding LEXX Stock Options 10,000 26 Apr 2024 Common Shares 5,000 $0.8700 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.